Jolly Healthcare launches standardised ketogenic diet formula to aid children with drug-resistant epilepsy

Jolly Healthcare introduces KETOJOL 4:1, a pharmaceutical-grade ketogenic diet formulation aimed at improving compliance and outcomes for children with drug-resistant epilepsy, supported by new patient education tools and clinician supervision. Jolly Healthcare has introduced KETOJOL 4:1, a ketogenic diet formulation…













